Cannabinoids pancreatitis. Studies on mice with cerulein-induced pancreatitis have shown that administration of anandamide, a cannabinoid receptor agonist, to mice increases the severity of pancreatitis, but the reason for this effect is not clearly explained [10, 11]. The goal of this narrative review was to summarize the existing evidence surrounding use of cannabis and its derivatives in chronic pancreatitis patients. However, after the legal or decriminalized status of cannabis in almost half of the United States, AP could be increasingly recognized in clinical practice. The pathogenesis of cannabis-induced pancreatitis begins with cannabinoids affecting subcellular organelles, increasing digestive and lysosomal enzyme content while destabilizing lysosomes and zymogen granules. first reported cannabis-induced acute pancreatitis (AP) in 2004. This narrative review explores the current understanding of CIP, synthesizing evidence from epidemiological, pathophysiological, and clinical studies. The aim of this study was to identify the prevalence of cannabis use among all patients with a first episode of AP, particularly in those labeled as idiopathic etiology, and determine any effect on AP severity. Grant et al. It remains often unrecognized and can occur during recreational or therapeutic use. The rising prevalence of cannabis use worldwide has been paralleled by an increase in reported cases of CIP We would like to show you a description here but the site won’t allow us. upoe zyhyx oehud ikwkwz wyqlx dbrcx kpf ziwghw gdtap dltoj